Epigenetic Enigmas

Overturning previous studies, a peculiar protozoan mysteriously uses a DNA-markup system to take out the genetic trash.

Written byBeth Marie Mole
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Wikimedia, Unknown SourceWhile most organisms use methyl marks on the genome to stake out gene expression, the fresh-water protozoan Oxytricha trifallax use the tags to kick junk DNA—95 percent of its genome—to the curb, according to a new study in Genome Biology published today (October 17). The finding refutes previous studies that concluded the ciliated single-cell critters—which usually carry four nuclei—have methylation-free DNA.

“It’s actually surprising that there is methylation, because it wasn't reported to be there—a lot of studies in the 80s and 90s looked for it and didn't find it,” said John R. Bracht, a postdoctoral researcher at Princeton University, and lead author of the study. “And what's kind of fun about this, is that it’s the exact same modification that you'll find in humans,” he added, “but it may be playing a different role.”

Oxytricha has a particularly peculiar life-cycle, with each organism containing two types of nuclei: a germ-line micronucleus that houses the entirety of the genome, but is transcriptionally silent, and a transcriptionally active macronucleus, which contains just 5 percent of the genome, explained senior author Laura Landweber, an evolutionary geneticist at Princeton. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies